Osteoblastic response as a healing reaction to chemotherapy mimicking progressive disease in patients with small cell lung cancer

European Radiology

Volumn 19, Issue 1, 2009, Pages 193-200

  Stattaus, Joerg ^a   Hahn, Steffen ^a   Gauler, Thomas ^a   Eberhardt, Wilfried ^a   Mueller, Stefan P ^a   Forsting, Michael ^a   Ladd, Susanne C ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Bone metastases; Osteoblastic response; SCLC

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPOTHILONE; ETOPOSIDE; IRINOTECAN; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METASTASIS; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DISEASE COURSE; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LUNG SMALL CELL CANCER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOBLASTIC RESPONSE; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OSTEOBLASTS; OSTEOGENESIS; SMALL CELL LUNG CARCINOMA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59249102228     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-1115-6     Document Type: Article

References (32)

1. Simon GR, Turrisi A (2007) Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:324S-339S
2. Takada M, Fukuoka M, Kawahara M, Sugiura T, Yokoyama A, Yokota S, Nishiwaki Y, Watanabe K, Noda K, Tamura T, Fukuda H, Saijo N (2002) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20:3054-3060
3. Samson DJ, Seidenfeld J, Simon GR, Turrisi AT, Bonnell C, Ziegler KM, Aronson N (2007) Evidence for management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:314S-323S
4. Argiris A, Murren JR (2001) Staging and clinical prognostic factors for small-cell lung cancer. Cancer J 7:437-447
5. Felip E, Pavlidis N, Stahel RA (2005) ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC). Ann Oncol 16(Suppl 1):i30-i31
6. Rosenthal DI (1997) Radiologic diagnosis of bone metastases. Cancer 80:1595-1607
7. Vinholes J, Coleman R, Eastell R (1996) Effects of bone metastases on bone metabolism: Implications for diagnosis, imaging and assessment of response to cancer treatment. Cancer Treat Rev 22:289-331
8. Hochstenbag MM, Snoep G, Cobben NA, Schols AM, Thunnissen FB, Wouters EF, ten Velde GP (1996) Detection of bone marrow metastases in small cell lung cancer. Comparison of magnetic resonance imaging with standard methods. Eur J Cancer 32A:779-782
9. Imamura F, Kuriyama K, Seto T, Hasegawa Y, Nakayama T, Nakamura S, Horai T (2000) Detection of bone marrow metastases of small cell lung cancer with magnetic resonance imaging: Early diagnosis before destruction of osseous structure and implications for staging. Lung Cancer 27:189-197
10. Layer G, Steudel A, Schuller H, van Kaick G, Grunwald F, Reiser M, Schild HH (1999) Magnetic resonance imaging to detect bone marrow metastases in the initial staging of small cell lung carcinoma and breast carcinoma. Cancer 85:1004-1009
11. Milleron BJ, Le Breton C, Carette MF, Cadranel JL, Akoun GM (1994) Assessment of bone marrow involvement by magnetic resonance imaging in small cell lung cancer. No significant change of staging. Chest 106:1030-1035
12. Seto T, Imamura F, Kuriyama K, Funakoshi T, Gotoh H, Nakayama T, Nakamura S, Horai T (1997) Effect on prognosis of bone marrow infiltration detected by magnetic resonance imaging in small cell lung cancer. Eur J Cancer 33:2333-2337
13. Basu S, Alavi A (2007) Defining co-related parameters between 'metabolic' flare and 'clinical', 'biochemical', and 'osteoblastic' flare and establishing guidelines for assessing response to treatment in cancer. Eur J Nucl Med Mol Imaging 34:441-443
14. Janicek MJ, Hayes DF, Kaplan WD (1994) Healing flare in skeletal metastases from breast cancer. Radiology 192:201-204
15. Lemieux J, Guimond J, Laberge F, St-Pierre C, Cormier Y (2002) The bone scan flare phenomenon in non-small-cell lung cancer. Clin Nucl Med 27:486-489
16. Vogel CL, Schoenfelder J, Shemano I, Hayes DF, Gams RA (1995) Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer. J Clin Oncol 13:1123-1128
17. Coleman RE, Mashiter G, Whitaker KB, Moss DW, Rubens RD, Fogelman I (1988) Bone scan flare predicts successful systemic therapy for bone metastases. J Nucl Med 29:1354-1359
18. Cosolo W, Morstyn G, Arkles B, Zimet AS, Zalcberg JR (1988) Flare responses in small cell carcinoma of the lung. Clin Nucl Med 13:13-16
19. Bellamy EA, Nicholas D, Ward M, Coombes RC, Powles TJ, Husband JE (1987) Comparison of computed tomography and conventional radiology in the assessment of treatment response of lytic bony metastases in patients with carcinoma of the breast. Clin Radiol 38:351-355
20. Theriault RL, Hortobagyi GN (1992) Bone metastasis in breast cancer. Anticancer Drugs 3:455-462
21. Pollen JJ, Shlaer WJ (1979) Osteoblastic response to successful treatment of metastatic cancer of the prostate. AJR Am J Roentgenol 132:927-931
22. DeMartini AL, Buzdar AU, Blumenschein GR (1983) Osteoblastic metastatic disease as a therapeutic response to adjuvant chemotherapy in breast cancer. J Surg Oncol 23:32-34
23. Amoroso V, Pittiani F, Grisanti S, Valcamonico F, Simoncini E, Ferrari VD, Marini G (2007) Osteoblastic flare in a patient with advanced gastric cancer after treatment with pemetrexed and oxaliplatin: implications for response assessment with RECIST criteria. BMC Cancer 7:94
24. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
25. Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT (2004) Bone imaging in metastatic breast cancer. J Clin Oncol 22:2942-2953
26. Quattrocchi CC, Santini D, Dell'aia P, Piciucchi S, Leoncini E, Vincenzi B, Grasso RF, Tonini G, Zobel BB (2007) A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid. Skeletal Radiol 36:1121-1127
27. Fischer BM, Mortensen J, Langer SW, Loft A, Berthelsen AK, Petersen BI, Daugaard G, Lassen U, Hansen HH (2007) A prospective study of PET/CT in initial staging of small-cell lung cancer: Comparison with CT, bone scintigraphy and bone marrow analysis. Ann Oncol 18:338-345
28. Bradley JD, Dehdashti F, Mintun MA, Govindan R, Trinkaus K, Siegel BA (2004) Positron emission tomography in limited-stage small-cell lung cancer: A prospective study. J Clin Oncol 22:3248-3254
29. Brink I, Schumacher T, Mix M, Ruhland S, Stoelben E, Digel W, Henke M, Ghanem N, Moser E, Nitzsche EU (2004) Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 31:1614-1620
30. Kamel EM, Zwahlen D, Wyss MT, Stumpe KD, von Schulthess GK, Steinert HC (2003) Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med 44:1911-1917
31. Niho S, Fujii H, Murakami K, Nagase S, Yoh K, Goto K, Ohmatsu H, Kubota K, Sekiguchi R, Nawano S, Saijo N, Nishiwaki Y (2007) Detection of unsuspected distant metastases and/or regional nodes by FDG-PET in LD-SCLC scan in apparent limited-disease small-cell lung cancer. Lung Cancer 57:328-333
32. Kut V, Spies W, Spies S, Gooding W, Argiris A (2007) Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET). Am J Clin Oncol 30:45-50